ASRT

Assertio Holdings, Inc. [ASRT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ASRT Stock Summary

Top 10 Correlated ETFs

ASRT


Top 10 Correlated Stocks

ASRT


In the News

04:05 29 Mar 2024 ASRT

Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

LAKE FOREST, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, today announced that it will release fourth quarter and full year 2023 financial results on Monday, March 11, 2024, after the market close. Following the release of its financial results, Assertio's management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

11:26 29 Mar 2024 ASRT

Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why

Assertio (ASRT) appears weighed down by the recent leadership transition. The company is also facing challenges with sales of its product franchisee of late.

12:03 29 Mar 2024 ASRT

Assertio Holdings: Here's A Contrarian Opportunity In The Health Care Sector

Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. Diversification is important in managing the risk associated with distressed equities like Assertio. I'm issuing a Buy rating but suggest diversifying.

11:18 29 Mar 2024 ASRT

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

Assertio (ASRT) appoints Heather Mason as its interim CEO as its current CEO, Dan Peisert, steps down from his role. Shares of the company fall on the same.

02:06 29 Mar 2024 ASRT

Pre-Surge Penny Picks: 3 Stocks to Buy Before They Boom

Today's backdrop of a predicted fall in interest rates, as well as the expectation that indices like the S&P 500 will surge higher, has some important considerations for penny stocks. Penny stocks tend to do better when the downward pressures on their valuations subside.

10:15 29 Mar 2024 ASRT

Assertio Holdings Inc. (ASRT) Q3 2023 Earnings Call Transcript

Assertio Holdings Inc. (NASDAQ:ASRT ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Matt Kreps - Darrow Associates, IR Dan Peisert - President and CEO Ajay Patel - SVP & Chief Accounting Officer Paul Schwichtenberg - SVP & CFO Conference Call Participants Thomas Flaten - Lake Street Capital Markets Jim Sidoti - Sidoti Scott Henry - ROTH MKM Partners Operator Good morning and welcome to the Assertio Holdings Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

12:06 29 Mar 2024 ASRT

Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023

LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release third quarter 2023 financial results on Wednesday, November 8, 2023, after the market close. Following the release of its financial results, Assertio's management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

04:41 29 Mar 2024 ASRT

Assertio Holdings: Uncovering A Tapestry Of Trading Opportunities From This Oversold Ticker

Assertio Holdings has undergone a significant transformation in its business model, reducing debt and exiting the opioid business. The company's recent performance has shown strong growth, with increased net product sales and improved gross margin. Assertio's stock is currently undervalued, trading at a significant discount, and has the potential for future growth and a turnaround.

09:46 29 Mar 2024 ASRT

Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?

Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.

10:32 29 Mar 2024 ASRT

Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?

Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.

ASRT Financial details

Company Rating
Neutral
Market Cap
98.8M
Income
-331.94M
Revenue
152.07M
Book val./share
1.46
Cash/share
0.78
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-0.4
Forward P/E
95.93
PEG
0.01
P/S
0.51
P/B
0.39
P/C
1.23
P/FCF
1.24
Quick Ratio
1.22
Current Ratio
1.62
Debt / Equity
0.29
LT Debt / Equity
0.28
-
-
EPS (TTM)
-3.95
EPS next Y
0.01
EPS next Q
-0.03
EPS this Y
-300.43%
EPS next Y
-100.13%
EPS next 5Y
-100.13%
EPS last 5Y
-17.6%
Revenue last 5Y
-7.9%
Revenue Q/Q
-7.42%
EPS Q/Q
-82.16%
-
-
-
-
SMA20
22.89%
SMA50
10.87%
SMA100
-53%
Inst Own
56.88%
Inst Trans
0.97%
ROA
-49%
ROE
-81%
ROC
-0.68%
Gross Margin
86%
Oper. Margin
-106%
Profit Margin
-110%
Payout
-
Shs Outstand
95M
Shs Float
89.35M
-
-
-
-
Target Price
-
52W Range
0.77-8.01
52W High
-
52W Low
-
RSI
48.16
Rel Volume
0.83
Avg Volume
1.12M
Volume
930.37K
Perf Week
-5.02%
Perf Month
18.61%
Perf Quarter
-62.23%
Perf Half Y
-62.82%
-
-
-
-
Beta
0.965
-
-
Volatility
0.03%, 0.1%
Prev Close
-3.1%
Price
0.9593
Change
-5.95%

ASRT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
12.984.052.62.92.14
Net income per share
-12.29-1.07-0.032.03-4.67
Operating cash flow per share
5.12-2.50.131.460.7
Free cash flow per share
5.03-2.50.131.450.69
Cash per share
2.380.790.861.21.03
Book value per share
3.282.122.44.191.94
Tangible book value per share
-19.38-5.52-2.660.510.38
Share holders equity per share
3.282.122.44.191.94
Interest debt per share
23.173.821.961.390.6
Market cap
88.4M37.74M93.09M231.78M76M
Enterprise value
397.55M101.06M129.77M233.71M43.47M
P/E ratio
-0.41-1.34-72.672.11-0.23
Price to sales ratio
0.390.360.841.480.5
POCF ratio
0.98-0.5816.852.951.53
PFCF ratio
0.99-0.5817.022.961.55
P/B Ratio
1.530.680.911.030.55
PTB ratio
1.530.680.911.030.55
EV to sales
1.730.951.171.50.29
Enterprise value over EBITDA
3.79-3.993.262.560.82
EV to operating cash flow
4.39-1.5423.52.970.88
EV to free cash flow
4.47-1.5423.722.980.89
Earnings yield
-2.46-0.75-0.010.47-4.37
Free cash flow yield
1.01-1.740.060.340.64
Debt to equity
6.061.510.720.30.29
Debt to assets
0.670.280.230.160.14
Net debt to EBITDA
2.94-2.50.920.02-0.61
Current ratio
0.560.710.771.391.83
Interest coverage
0.05-2.950.927.267.38
Income quality
-0.422.33-4.310.72-0.15
Dividend Yield
00000
Payout ratio
00-0.1500
Sales general and administrative to revenue
0.470.980.490.280
Research and developement to revenue
0.040.04000.02
Intangibles to total assets
0.760.660.660.480.39
Capex to operating cash flow
-0.020-0.010-0.01
Capex to revenue
-0.010000
Capex to depreciation
-0.0100-0.01-0.02
Stock based compensation to revenue
0.050.10.030.050.06
Graham number
30.17.151.2713.8414.29
ROIC
0.01-0.20.120.70.18
Return on tangible assets
-1.72-0.27-0.010.51-1.9
Graham Net
-22.25-7.17-3.52-1.53-0.29
Working capital
-80.6M-38.43M-31.52M36.95M77.62M
Tangible asset value
-342.58M-144.57M-113.64M27.73M26.67M
Net current asset value
-365.26M-153.51M-120.64M-55.93M22.65M
Invested capital
6.061.510.720.30.29
Average receivables
39.98M43.55M44.36M44.86M46.51M
Average payables
11.17M15.5M10.75M6.34M9.72M
Average inventory
3.4M7.56M9.6M10.59M25.69M
Days sales outstanding
67.98152.32145.85105.96114.4
Days payables outstanding
621.82271.99154.12116.6488.79
Days of inventory on hand
131.02215.12172.66266.64248.98
Receivables turnover
5.372.42.53.443.19
Payables turnover
0.591.342.373.134.11
Inventory turnover
2.791.72.111.371.47
ROE
-3.75-0.51-0.010.49-2.41
Capex per share
-0.0800-0.01-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.760.850.580.440.35
Net income per share
1.34-0.070.12-3.42-0.61
Operating cash flow per share
0.40.460.270.030.06
Free cash flow per share
0.40.450.260.030.06
Cash per share
0.981.3810.940.78
Book value per share
3.425.043.622.361.46
Tangible book value per share
0.421.180.980.030.28
Share holders equity per share
3.425.043.622.361.46
Interest debt per share
1.030.80.560.50.42
Market cap
283.82M317.04M380.18M209.19M101.3M
Enterprise value
285.75M287.06M348.26M171.16M68.77M
P/E ratio
0.8-22.7511.22-0.19-0.44
Price to sales ratio
5.647.479.275.873.07
POCF ratio
10.6313.9620.4481.1117.75
PFCF ratio
10.7414.0221.2481.1117.21
P/B Ratio
1.261.261.51.080.73
PTB ratio
1.261.261.51.080.73
EV to sales
5.676.768.54.82.08
Enterprise value over EBITDA
9.5613.6117.5926.1-56.14
EV to operating cash flow
10.712.6418.7266.3712.05
EV to free cash flow
10.8112.719.4666.3711.68
Earnings yield
0.31-0.010.02-1.34-0.57
Free cash flow yield
0.090.070.050.010.06
Debt to equity
0.30.150.150.210.29
Debt to assets
0.160.090.090.10.14
Net debt to EBITDA
0.06-1.42-1.61-5.826.55
Current ratio
1.391.461.681.621.83
Interest coverage
16.5513.0216.54-303.55-8.12
Income quality
0.3-6.522.2-0.01-0.1
Dividend Yield
000.0400
Payout ratio
001.9300
Sales general and administrative to revenue
0.20000
Research and developement to revenue
000.010.040.03
Intangibles to total assets
0.480.460.460.50.39
Capex to operating cash flow
-0.010-0.0400.03
Capex to revenue
-0.010-0.0200.01
Capex to depreciation
-0.03-0.02-0.1100.04
Stock based compensation to revenue
0.050.060.050.050.08
Graham number
10.162.823.1413.484.46
ROIC
0.770.030.03-1.19-0.06
Return on tangible assets
0.41-0.020.04-1.47-0.33
Graham Net
-1.25-1.05-0.57-0.51-0.22
Working capital
36.95M43.3M54.07M70.67M77.62M
Tangible asset value
27.73M58.95M68.84M2.6M26.67M
Net current asset value
-55.93M-25.76M-17.36M-2.2M22.65M
Invested capital
0.30.150.150.210.29
Average receivables
45.02M45.91M44.04M52.04M55.07M
Average payables
7.18M6.08M8.68M15.09M16.22M
Average inventory
13.98M14.96M17.52M30.76M40.2M
Days sales outstanding
81.0798.4891.35157.8130.05
Days payables outstanding
89.64101.62210.89242.2682.68
Days of inventory on hand
204.93267.12354.89544.46231.87
Receivables turnover
1.110.910.990.570.69
Payables turnover
10.890.430.371.09
Inventory turnover
0.440.340.250.170.39
ROE
0.39-0.010.03-1.45-0.42
Capex per share
00-0.0100

ASRT Frequently Asked Questions

What is Assertio Holdings, Inc. stock symbol ?

Assertio Holdings, Inc. is a US stock , located in Lake forest of Il and trading under the symbol ASRT

What is Assertio Holdings, Inc. stock quote today ?

Assertio Holdings, Inc. stock price is $0.9593 today.

Is Assertio Holdings, Inc. stock public?

Yes, Assertio Holdings, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap